Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine Plus Cisplatin in Locally Advanced Breast Cancer
NCT06531447Phase 2Active, not recruiting
- Sponsor
- National Center of Oncology
- Start
- May 2014
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, cisplatin in breast cancer, sponsored by National Center of Oncology. Started May 2014; status: active, not recruiting.
02
Drugs
gemcitabinecisplatin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT06531447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06531447.